Integrating Image-Based Design and 3D Biomaterial Printing to Create Patient Specific Devices within a Design Control Framework for Clinical Translation
dc.contributor.author | Hollister, SJ | |
dc.contributor.author | Flanagan, CL | |
dc.contributor.author | Morrison, RJ | |
dc.contributor.author | Patel, JJ | |
dc.contributor.author | Wheeler, MB | |
dc.contributor.author | Edwards, SP | |
dc.contributor.author | Green, GE | |
dc.coverage.spatial | United States | |
dc.date.accessioned | 2024-01-09T16:59:02Z | |
dc.date.available | 2024-01-09T16:59:02Z | |
dc.date.issued | 2016-10-10 | |
dc.identifier.issn | 2373-9878 | |
dc.identifier.issn | 2373-9878 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/31231678 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/191956 | en |
dc.description.abstract | Despite significant advances in 3D biomaterial printing, the potential of 3D printing for patient specific implants and tissue reconstruction has not been fully exploited. This is due in part to the lack of integration of image-based patient specific design with 3D biomaterial printing within a relevant regulatory framework, namely design control, required by the FDA. In this manuscript, we describe the integration of image-based, multiscale patient specific design with 3D biomaterial printing within a design control framework for clinical translation. Specifically, we define design inputs for patient specific implants and scaffolds, and utilize image-based patient specific design to achieve these design inputs. We then illustrate realization of these topology designed patient specific implants by laser sintering of polycaprolactone (PCL). Finally, we present initial results in large animal models using 3D printed PCL implants addressing two challenging problems in tissue reconstruction: 1) designing and 3D printing implantable devices to allow growth in pediatric airway applications and 2) utilizing 3D printed scaffolds as foundations for prefabricated flaps to obtain vascularization and bone formation for large volume bone/soft tissue reconstruction. We illustrate these challenging problems as they need to be incorporated in design control, but as of yet there are few data to direct how growth and vascularization should be utilized in design control. | |
dc.format.medium | Print-Electronic | |
dc.language | eng | |
dc.publisher | American Chemical Society (ACS) | |
dc.subject | 3D Printing | |
dc.subject | Airway Splint | |
dc.subject | Clinical Translation | |
dc.subject | Design Control | |
dc.subject | Image-Based Design | |
dc.subject | Patient Specific Implants | |
dc.subject | Prefabricated Flap | |
dc.title | Integrating Image-Based Design and 3D Biomaterial Printing to Create Patient Specific Devices within a Design Control Framework for Clinical Translation | |
dc.type | Article | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/191956/2/2016_ACS Biomater_3D Printing Design Control.pdf | |
dc.identifier.doi | 10.1021/acsbiomaterials.6b00332 | |
dc.identifier.doi | https://dx.doi.org/10.7302/21957 | |
dc.identifier.source | ACS Biomaterials Science and Engineering | |
dc.description.version | Published version | |
dc.date.updated | 2024-01-09T16:59:00Z | |
dc.identifier.orcid | 0000-0002-2313-8542 | |
dc.identifier.orcid | 0000-0002-5156-9542 | |
dc.identifier.volume | 2 | |
dc.identifier.issue | 10 | |
dc.identifier.startpage | 1827 | |
dc.identifier.endpage | 1836 | |
dc.identifier.name-orcid | Hollister, SJ | |
dc.identifier.name-orcid | Flanagan, CL | |
dc.identifier.name-orcid | Morrison, RJ; 0000-0002-2313-8542 | |
dc.identifier.name-orcid | Patel, JJ | |
dc.identifier.name-orcid | Wheeler, MB | |
dc.identifier.name-orcid | Edwards, SP | |
dc.identifier.name-orcid | Green, GE; 0000-0002-5156-9542 | |
dc.working.doi | 10.7302/21957 | en |
dc.owningcollname | Biomedical Engineering, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.